Commission Implementing Regulation (EU) 2025/1490 of 24 July 2025 amending Implementing Regulation (EU) No 564/2013 as regards the adaptation of fees to inflation

• CELEX: Implementing Regulation (EU) 2025/1490
• Articles: 4

Article 1

Regulation (EU) No 564/2013 is amended as follows:

(1)

Annexes I and II are amended in accordance with Annex I to this Regulation;

(2)

Annex III is replaced by the text set out in Annex II to this Regulation.

Article 2

This Regulation shall enter into force on the twentieth day following that of its publication in the Official Journal of the European Union .

Schedules & Appendices

ANNEX I

ANNEX I

Annexes I and II of Regulation (EU) No 564/2013 are amended as follows:

(1)

in Annex I, Table 1 is replaced with the following:

‘Table 1

Standard fees

General description of task; relevant provision in Regulation (EU) No 528/2012

Specific condition or task description

Fee (EUR)

Approval of an active substance; Article 7(2)

Fee for the first product-type for which that active substance is approved

143 400

Additional fee per additional product-type

47 800

Additional fee per product-type (for both the first product-type and any additional product-type) if the active substance is a candidate for substitution in accordance with Article 10 of Regulation (EU) No 528/2012

23 900

Fee for the amendment of an approval, other than the addition of a product-type

23 900

Renewal of an approval; Article 13(3)

Fee for the first product-type for which renewal of that active substance is sought

17 925

Additional fee per additional product-type

1 793

Additional fee for the first product-type for which renewal of that active substance is sought in case a full evaluation is found necessary in accordance with Article 14(1) of Regulation (EU) No 528/2012

29 875

Additional fee per additional product-type in case a full evaluation is found necessary in accordance with Article 14(1) of Regulation (EU) No 528/2012

2 988

Additional fee per product-type (for both the first product-type and any additional product-type) if the active substance is a candidate for substitution in accordance with Article 10 of Regulation (EU) No 528/2012

23 900

Inclusion in Annex I of an active substance; Article 28

Fee for the first inclusion in Annex I of an active substance

11 950

Fee for the amendment of an inclusion of an active substance in Annex I

2 390

Notification in accordance with Article 17(4) of Commission Delegated Regulation (EU) No 1062/2014  ( 1 )

Fee per substance/product-type combination.

The fee for the notification shall be deducted from the subsequent application for approval

11 950

(2)

in Annex II, Table 1 is replaced with the following:

‘Table 1

Standard fees

General description of task; relevant provision in Regulation (EU) No 528/2012

Specific condition or task description

Fee (EUR)

Granting of Union authorisation, single product; Article 43(2)

Fee per product not identical with (one of) the representative product(s) assessed for the purpose of the substance approval

95 600

Fee per product identical with (one of) the representative product(s) assessed for the purpose of the substance approval

47 800

Additional fee per product when comparative assessment in accordance with Article 23 of Regulation (EU) No 528/2012 is required

47 800

Additional fee per product when the requested authorisation is provisional in accordance with Article 55(2) of Regulation (EU) No 528/2012

11 950

Granting of Union authorisation, biocidal product family; Article 43(2)

Fee per family

179 250

Additional fee per family when comparative assessment in accordance with Article 23 of Regulation (EU) No 528/2012 is required

71 700

Additional fee per family when the requested authorisation is provisional in accordance with Article 55(2) of Regulation (EU) No 528/2012

17 925

Notification to the Agency of an additional product within a biocidal product family; Article 17(6)

Fee per additional product

2 390

Union authorisation of a same biocidal product; Article 17(7)

Fee per product constituting a ‘same product’ within the meaning of Commission Implementing Regulation (EU) No 414/2013

( 2 )

2 390

Major change of an authorised product or product family; Article 50(2)

Fee per application

47 800

Minor change of an authorised product or product family; Article 50(2)

Fee per application

17 925

Administrative change of an authorised product or product family; Article 50(2)

Fee per notification

2 390

Recommendation on the classification of a change of an authorised product or product family; Article 50(2)

Fee per request in accordance with Commission Implementing Regulation (EU) No 354/2013  ( 3 )

If the recommendation is to classify the change as an administrative or minor change, the fee for the request shall be deducted from the subsequent application or notification in accordance with Implementing Regulation (EU) No 354/2013

2 390

Renewal of Union authorisation, single product; Article 45(3)

Fee per product

5 975

Additional fee per product in case a full evaluation is found necessary in accordance with Article 14(1) of Regulation (EU) No 528/2012

17 925

Additional fee per product when comparative assessment in accordance with Article 23 of Regulation (EU) No 528/2012 is required

47 800

Renewal of Union authorisation, biocidal product family; Article 45(3)

Fee per product family

8 963

Additional fee per product family in case a full evaluation is found necessary in accordance with Article 14(1) of Regulation (EU) No 528/2012

26 888

Additional fee per product family when comparative assessment in accordance with Article 23 of Regulation (EU) No 528/2012 is required

71 700

( 1 )   Commission Delegated Regulation (EU) No 1062/2014 of 4 August 2014 on the work programme for the systematic examination of all existing active substances contained in biocidal products referred to in Regulation (EU) No 528/2012 of the European Parliament and of the Council ( OJ L 294, 10.10.2014, p. 1 , ELI: http://data.europa.eu/eli/reg_del/2014/1062/oj ).’

( 2 )   Commission Implementing Regulation (EU) No 414/2013 of 6 May 2013 specifying a procedure for the authorisation of same biocidal products in accordance with Regulation (EU) No 528/2012 of the European Parliament and of the Council ( OJ L 125, 7.5.2013, p. 4 ., ELI: http://data.europa.eu/eli/reg_impl/2013/414/oj ).

( 3 )   Commission Implementing Regulation (EU) No 354/2013 of 18 April 2013 on changes of biocidal products authorised in accordance with Regulation (EU) No 528/2012 of the European Parliament and of the Council ( OJ L 109, 19.4.2013, p. 4 , ELI: http://data.europa.eu/eli/reg_impl/2013/354/oj ).’

ANNEX II

ANNEX II

‘ANNEX III

Other fees

General description of task; relevant provision in Regulation (EU) No 528/2012

Specific condition or task description

Fee (EUR)

Technical equivalence; Article 54(3)

Fee, when difference between the active substance sources is limited to a change in manufacturing location, and application is based solely on analytical data

5 975

Fee, when difference between the active substance sources goes beyond a change in the manufacturing location, and application is based solely on analytical data

23 900

Fee when previous conditions are not met.

47 800

Annual fee for biocidal products authorised by the Union; Article 80(1)(a)

Fee per Union authorisation of a biocidal product

11 950

Fee per Union authorisation of a biocidal product family

23 900

Mutual Recognition Submission fee; Article 80(1)(a)

Fee per product or product family concerned by an application for mutual recognition, per Member State where mutual recognition is sought

837

Appeal; Article 77(1)

Fee per appeal

2 988

Submission for inclusion in the list of relevant persons; Article 95

Fee per submission of a letter of access to a dossier already found complete by the Agency or an evaluating Competent Authority

2 390

Fee per submission of a letter of access to part of a dossier already found complete by the Agency or an evaluating Competent Authority, together with complementary data

23 900

Fee per submission of a new dossier

47 800

Requests under Article 66(4) submitted to the Agency

Fee per item for which confidentiality is requested

1 195

’